METOPROLOLIN VAIKUTUS ANESTESIAAN, KIPULÄÄKKEEN TARPEESEEN JA KIVUN ILMENEMISEEN RINTASYÖPÄLEIKKAUSPOTILAILLA

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2014-001900-23-FI

Enrollment

Registered

2014-08-26

Start date

2014-10-01

Completion date

Unknown

Last updated

2025-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 17.0 Level: LLT Classification code 10006192 Term: Breast cancer NOS System Organ Class: 100000004864

Interventions

Trade Name: Seloken 1 mg/ml inj. liuos Pharmaceutical Form: Solution for infusion INN or Proposed INN: METOPROLOL Other descriptive name: METOPROLOL TARTRATE Pharmaceutical form of the placebo: Soluti

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 70 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Contacts

Public ContactJari Halonen

Jari Halonen

jari.halonen@kuh.fi

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026